National Institute on Aging; Notice of Closed Meeting, 39200-39201 [2020-14058]
Download as PDF
<![CDATA[
39200
ACTION:
Federal Register / Vol. 85, No. 126 / Tuesday, June 30, 2020 / Notices
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30 days of the date of this
publication.
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, contact: Robert
M. Lembo, MD, Office of Clinical
Research Training and Medical
Education, NIH Clinical Center,
National Institutes of Health, 10 Center
Drive, Room 1N252C, Bethesda, MD
20892–1158, or call non-toll-free
ADDRESSES:
number (301) 496–2636, or Email your
request, including your address to:
robert.lembo@nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on April 16, 2020, page 21255–
21256 (85 FR 21255–21256) and
allowed 60 days for public comment.
One comment was received. The
purpose of this notice is to allow an
additional 30 days for public comment.
The Clinical Center, National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection Title:
Application Process for Clinical
Research Training and Medical
Education at the NIH Clinical Center,
OMB #0925–0698, Expiration date July
31, 2020, REVISION, National Institutes
of Health Clinical Center (CC), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The primary objective of the
application process is to allow the
Office of Clinical Research Training and
Medical Education (OCRTME) at the
NIH Clinical Center to evaluate
applicants’ qualifications to determine
applicants’ eligibility for courses and
training programs managed by the
Office. Applicants must provide the
required information requested in the
respective applications to be considered
a candidate for participation.
Information submitted by candidates for
training programs is reviewed initially
by OCRTME administrative staff to
establish eligibility for participation.
Eligible candidates are then referred to
the designated training program
director/administrator or training
program selection committee for review
and decisions regarding acceptance for
participation. A secondary objective of
the application process is to track
enrollment in courses and training
programs over time.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours is
333.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden
per response
(in hours)
Total
annual
burden
hours
Type of respondents
Clinical Electives Program ................
Graduate Medical Education ............
Medical Research Scholars Program
Resident Electives Program .............
Bioethics Fellowship Program ..........
Pre Doctoral Students ......................
Physicians ........................................
Pre Doctoral Students ......................
Physicians ........................................
Pre Doctoral, Post-Doctoral .............
300
100
200
100
300
1
1
1
1
1
20/60
20/60
20/60
20/60
20/60
100
33
67
33
100
Total ...........................................
...........................................................
........................
1000
........................
333
Dated: June 25, 2020.
Laura M. Lee,
Project Clearance Liaison, NIH Clinical
Center, National Institutes of Health.
[FR Doc. 2020–14057 Filed 6–29–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Form name
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
VerDate Sep<11>2014
18:18 Jun 29, 2020
Jkt 250001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Long-Term
Services for Dementia Care.
Date: July 17, 2020.
Time: 10:00 a.m. to 1:00 p.m.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Kimberly Firth,
Ph.D.,Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building, 7201 Wisconsin Avenue, Suite
2W200, Bethesda, MD 20892, (301) 402–
7702, firthkm@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
E:\FR\FM\30JNN1.SGM
30JNN1
Federal Register / Vol. 85, No. 126 / Tuesday, June 30, 2020 / Notices
Dated: June 25, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–14058 Filed 6–29–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Conflicts in
Nephrology.
Date: July 27, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jonathan K. Ivins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2190,
MSC 7850, Bethesda, MD 20892, (301) 594–
1245, ivinsj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Biology.
Date: July 27, 2020.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Amy L. Rubinstein, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5152,
MSC 7844, Bethesda, MD 20892, 301–408–
9754, rubinsteinal@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Cardiovascular Sciences.
Date: July 28–29, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
18:18 Jun 29, 2020
Jkt 250001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bradley Nuss, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC 7814, Bethesda, MD 20892, 301–451–
8754, nussb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
conflicts: Topics in Hepatology,
Pharmacology, and Environmental
Toxicology.
Date: July 28, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aiping Zhao, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2188,
MSC 7818, Bethesda, MD 20892–7818, (301)
435–0682, zhaoa2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 24, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–14022 Filed 6–29–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Letters of Interest (LOI) for
NCI–MATCH Laboratories
National Institutes of Health,
Health and Human Services (HHS).
ACTION: Notice, extension.
AGENCY:
The National Cancer Institute
(NCI) through its National Clinical
Trials Network (NCTN) is developing a
successor precision medicine trial to
‘NCI-Molecular Analysis for Therapy
Choice (NCI–MATCH)’ entitled ‘NCIComboMATCH’. The principal of this
intiative is to overcome drug resistance
to single-agent therapy by developing
genomically-directed targeted agent
combinations. All combinations must be
supported by robust, preclinical in vivo
evidence. Due to the coronavirus
pandemic the NCI is providing an
extension of the previously published
notice in the Federal Register on March
11, 2020 to allow candidate more time
to submit LOIs. NCI-ComboMATCH trial
leadership invites applications for
SUMMARY:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
39201
Clinical Laboratory Improvements
Program (CLIA) certified/accredited
laboratories that test tumor specimens
from patients utilizing Next-Generation
Sequencing (NGS) assays to participate
in the NCI-ComboMATCH trial. In order
to support this trial, the designated
laboratories participating in NCIComboMATCH will identify patients for
the specific variants needed for trial
eligibility. Laboratories will be required
to contact any of the NCTN sites that
have activated NCI-ComboMATCH if a
specimen sent from one of these sites
has a variant(s) that would potentially
make the patient eligible for one of the
treatment arms.
DATES: The due date for Letters of
Interest (LOIs), published on March 11,
2020 (85 FR 14208), has been extended
and should now be submitted to the
National Cancer Institute (NCI),
National Institutes of Health (NIH) on or
before 5:00 p.m. EST on September 30,
2020.
ADDRESSES: Submit LOIs by email to
NCICOMBOMATCHLabApps@nih.gov.
9609 Medical Center Drive, 3 West,
Room 526, MSC 9728, Rockville, MD
20892.
FOR FURTHER INFORMATION CONTACT:
Questions about this request for LOIs
should be directed to
NCICOMBOMATCHLabApps@nih.gov.
James V. Tricoli, 240–276–5725 or
tricolij@mail.nih.gov, can also provide
further information.
SUPPLEMENTARY INFORMATION: This
notice was previously published in the
Federal Register on March 11, 2020,
page 14208–14210 (85 FR 14208). The
purpose of this notice is to allow an
additional 90 days for submission of the
LOI. The due date for LOI submission
has been extended from the previous
date of June 30, 2020 to September 30,
2020 to allow more labs to submit. This
is necessary due to the impact of the
coronavirus pandemic. In accordance
with 42 U.S.C. 285, of the Public Health
Service Act, as amended. Similar to
NCI–MATCH, NCI-ComboMATCH is
conceived as a signal-seeking study. The
NCI-ComboMATCH team will
determine whether patients with tumor
mutations, amplifications or
translocations in the genetic pathway(s)
of interest are likely to derive clinical
benefit if treated with a combination of
precision medicine agents targeting
those specific pathway(s). This
recruitment is for labs that can
specifically screen 200 patients seen at
NCTN sites per month.
Patients with histologically
documented solid tumors, lymphomas
and multiple myeloma whose disease
has progressed following at least one
E:\FR\FM\30JNN1.SGM
30JNN1
]]>Agencies
[Federal Register Volume 85, Number 126 (Tuesday, June 30, 2020)]
[Notices]
[Pages 39200-39201]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-14058]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Long-Term Services for Dementia Care.
Date: July 17, 2020.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892 (Video Meeting).
Contact Person: Kimberly Firth, Ph.D.,Scientific Review Officer,
Scientific Review Branch, National Institute on Aging, National
Institutes of Health, Gateway Building, 7201 Wisconsin Avenue, Suite
2W200, Bethesda, MD 20892, (301) 402-7702, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
[[Page 39201]]
Dated: June 25, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-14058 Filed 6-29-20; 8:45 am]
BILLING CODE 4140-01-P
